Europe Has Its Own Biotech Star as Argenx Soars on Trial Success
It’s been a big week for biotech stocks on both sides of the Atlantic.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
More in Finance & Markets
Quadria Capital-backed Nobel Hygiene files papers with SEBI to raise funds via IPO
The proposed IPO comprises a fresh issue of shares worth up to ₹150 crore and an Offer-for-Sale of up to 1.55 crore equity shares by promoters and existing investors
Foreign reserves amount to QR202.2bn amid robust financial stability
<p>DOHA: The Qatar Central Bank (QCB) yesterday reported a comprehensive overview of Qatar’s monetary and institutional developments, highlighting key achievements that strengthened the financial sector’s overall resilience and inclusiveness.</p> <p>In its 2025 Annual Report, the central bank reported that financial stability remained…
Argentina Economy Grew 2.7% in June While Country Risk Hit a Three-Month High
Argentina economy expanded 2.7% in June from a year earlier, while country risk climbed to a three-month high of 517 basis points.
- Argentina's economy grew 2.7% in June, driven by mining and agriculture.
- Country risk hit a three-month high of 517 basis points on August 19, 2026.
- UN ECLAC projects Argentina's 2026 growth at 3.3%.
US Dollar: Treasury twist signals structural risks – Commerzbank
Commerzbank’s Volkmar Baur notes the US Dollar remains under pressure as EUR/USD trades around 1.17 following the US Treasury’s expansion of its Liquidity Support Buyback Operations.